Compositions for creatine supplementation in creatine non-responders
Disclosed herein are methods for creatine supplementation for human subjects, particularly creatine non-responders.
1. A method of increasing creatine absorption in muscles in a human subject in need thereof, the method comprising co-administering to said human subject a supplemental amount of creatine, an effective amount of effective amount of creatinine, and a source of nitrate anion (NO 3 —), wherein the source of nitrate anion (NO 3 —) provides an effective amount of nitrate anion (NO 3 —).
2. The method of claim 1 , wherein the human subject is a creatine non-responder.
3. The method of claim 1 , wherein the co-administering comprises administering to the human subject a composition comprising:
the supplemental amount of creatine;
the effective amount of creatinine; and
the source of nitrate anion (NO 3 − ).
4. The method of claim 1 , wherein the supplemental amount of creatine is at least 500 mg, the effective amount of creatinine is at least 500 mg and the effective amount of the nitrate anion (NO 3 − ) is at least 50 mg.
5. The method of claim 1 , wherein the supplemental amount of creatine is at least 1000 mg, the effective amount of creatinine is at least 1000 mg, and the effective amount of nitrate anion (NO 3 − ) is at least 100 mg.
6. The method of claim 1 , wherein the supplemental amount of creatine is at least 2 grams, the effective amount of creatinine is at least 2 grams, and the effective amount of nitrate anion (NO 3 − ) is at least 500 mg.
7. The method of claim 1 , wherein the supplemental amount of creatine is at least 5 grams, the effective amount of creatinine is at least 3 grams, and the effective amount of nitrate anion (NO 3 − ) is at least 1000 mg.
8. The method of claim 1 , wherein the supplemental amount of creatine is at least between 500 mg and 20000 mg, the effective amount of creatinine is at between 500 mg and 30000 mg, and the effective amount of the nitrate anion (NO 3 − ) is at between 50 mg and 3000 mg.